| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.091 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |